InsiderTrades

Form 4 for SHW Sherwin-Williams

Accepted 2023-10-25 00:00:00 ET · period of report 2023-10-25 · accession 0001209191-23-053537 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
M 2023-10-25 2023-10-25 SHW MORIKIS JOHN G COB, CEO, Dir P - Purchase $237.60 +2,125 316.8K +0.7% +$504.9K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-10-25 P A 500 $238.36 317,270 D — — (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $238.360 to $238.365 inclusive. The reporting person undertakes to provide to The Sherwin-Williams Company, any security holder of The Sherwin-Williams Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. (F3) Includes 51,305 shares of common stock previously reported as indirectly owned by the reporting person through a grantor retained annuity trust (GRAT), which were distributed to the reporting person since the date of his last report in accordance with the terms of the GRAT, and which are now directly owned by him.
2 Common Common Stock 2023-10-25 P A 1,625 $237.36 316,770 D — — (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $236.940 to $237.610 inclusive. The reporting person undertakes to provide to The Sherwin-Williams Company, any security holder of The Sherwin-Williams Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.